The Cooper Companies, Inc. $COO Shares Acquired by London Co. of Virginia

London Co. of Virginia boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 7.8% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 2,237,145 shares of the medical device company’s stock after purchasing an additional 162,766 shares during the quarter. London Co. of Virginia’s holdings in Cooper Companies were worth $159,956,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in COO. Root Financial Partners LLC increased its stake in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 162 shares during the last quarter. SJS Investment Consulting Inc. grew its position in shares of Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after buying an additional 187 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new stake in Cooper Companies during the 2nd quarter worth $36,000. Cromwell Holdings LLC boosted its stake in Cooper Companies by 128.8% in the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after acquiring an additional 273 shares in the last quarter. Finally, MUFG Securities EMEA plc acquired a new position in Cooper Companies in the second quarter valued at $42,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $70.31 on Friday. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The firm has a market capitalization of $13.71 billion, a P/E ratio of 59.58, a PEG ratio of 1.84 and a beta of 0.84. The company’s fifty day moving average is $67.34 and its two-hundred day moving average is $72.19. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently issued reports on COO. JPMorgan Chase & Co. decreased their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. Needham & Company LLC decreased their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Wells Fargo & Company reissued a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Robert W. Baird reduced their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. Finally, Mizuho set a $85.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a research note on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, Cooper Companies currently has an average rating of “Hold” and a consensus target price of $81.85.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.